FindTrial
Sign In

usefulness of vitamin c in the reduction of blood pressure and fat levels in mild to moderate hypertensive patients.

Evaluation of Efficacy and Safety of Vitamin C as an add on therapy to telmisartan in the reduction of blood pressure and lipid levels in mild to moderate hypertensive patients in tertiary care hospital â?? A Randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036310
Enrollment
110
Registered
2021-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10-I16- Hypertensive diseases

Interventions

Intervention1: Vitamin C: Vitamin C 500mg once daily fot 4 months Control Intervention1: not applicable: not applicable

Sponsors

Dr V DIVYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients taking telmisartan for hypertension 2.Patients with mild to moderate hypertension 3.Patients willing to give written informed consent

Exclusion criteria

Exclusion criteria: 1.Patient age 65 years 2.Uncontrolled Hypertension 3.Previous history of malignancy 4.Previous history of myocardial infection 5.Current or potential pregnancy / Lactation 6.Chronic kidney disease 7.H/O psychiatric illness

Design outcomes

Primary

MeasureTime frame
Reduction in blood pressureTimepoint: 0,20 weeks—

Secondary

MeasureTime frame
1)Reduction in lipid levels 2)Reduction in Atherogenic index of plasma Timepoint: 0,20 WEEKS—

Countries

India

Contacts

Public ContactDivya V

SRM MEDICAL COLLEGE AND RESEARCH CENTRE

hod.medpharm.ktr@srmist.edu.in9840279010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026